Vanguard Group’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.35B Sell
17,026,542
-94,656
-0.6% -$7.25M 0.02% 596
2025
Q3
$1.25B Buy
17,121,198
+867,837
+5% +$63.6M 0.02% 618
2025
Q2
$1.23B Buy
16,253,361
+29,460
+0.2% +$2.09M 0.02% 603
2025
Q1
$1.23B Sell
16,223,901
-42,992
-0.3% -$3.2M 0.02% 582
2024
Q4
$1.07B Buy
16,266,893
+75,631
+0.5% +$5.29M 0.02% 637
2024
Q3
$1.13B Sell
16,191,262
-110,516
-0.7% -$6.65M 0.02% 622
2024
Q2
$862M Buy
+16,301,778
New +$990M 0.02% 697

Other funds holding SOLV

Vanguard Group's SOLV Position: Q4 2025 in Review

Vanguard Group reduced its Solventum (SOLV) stake by 0.55% in Q4 2025, selling an estimated $7.25M and leaving 17,026,542 shares worth $1.35B. The position accounts for 0.02% of the portfolio, ranked #596.

Vanguard Group first reported a position in SOLV in Q2 2024 and has held it in 7 quarters since. 938 funds tracked by Wall St. Rank hold SOLV as of Q4 2025.

  • Vanguard Group held 17,026,542 shares of Solventum worth $1.35B as of Q4 2025.
  • Vanguard Group sold 94,656 Solventum shares in Q4 2025, an estimated $7.25M.
  • Solventum made up 0.02% of Vanguard Group's portfolio in Q4 2025, its #596 holding.
  • Vanguard Group first reported a position in Solventum in Q2 2024 and has held it in 7 quarters since.
  • 938 funds tracked by Wall St. Rank held Solventum as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.